Search Results

Ordering information regarding an HPV Self Collection Screen for Clinical Diagnostic Laboratories. HPV Self-Collection Screening (HPV-SCS) Ordering Recommendation The HPV Cervical Cancer Self-Collection Test is a highly sensitive screening tool that enables patients to collect their own vaginal sample using an FDA-approved device. After collection, the specimen is processed using advanced nucleic acid amplification methods (typically PCR-based) to qualitatively detect high-risk HPV DNA associated with cervical cancer. This self-collected approach offers comparable diagnostic accuracy to traditional clinician-collected samples while minimizing discomfort and barriers associated with pelvic examinations, making it an effective option for early detection and timely clinical follow-up. Mnemonic HPV Self-Collection Screening (HPV-SCS) Methodology The specimen is processed using nucleic acid amplification techniques (generally PCR-based methods) to qualitatively detect the presence of high-risk HPV DNA. Performed Mon-Sat Reported Within 3-5 days Specimen Required Patient Preparation: Collect: Wash your hands and remove the sterile self-collection device before gently inserting it into the vagina up to the indicated marker. Rotate the device 2–3 times as instructed to collect an adequate sample, then carefully withdraw it. Refrain from douching, using intravaginal medications, or applying topical agents for at least 48 hours prior to collection. • Avoid sexual intercourse for 24–48 hours before sample collection. • If menstruating, confirm with the provider whether sample collection should be postponed until menses have ceased. Specimen Preparation: Immediately place the collection device into the provided vial containing the appropriate viral transport medium. Secure the vial cap tightly and gently invert the vial to mix the specimen with the medium. Ensure that the specimen is labeled accurately with patient identification and collection date/time. Storage/Transport Temperature: Maintain at 2–8°C during storage and transport. Avoid freezing unless the test kit instructions specifically allow it. Prompt transport to the laboratory is advised to maintain sample integrity. Unacceptable Conditions: Specimens that are unlabeled or improperly labeled. Inadequate sample volume or insufficient cellular material. Contaminated samples (e.g., with menstrual blood or external substances) beyond acceptable limits. Specimens showing leakage or compromised container integrity. Samples exposed to temperatures outside the recommended range prior to processing Remarks: Specimen source required. Stability: Reference Interval Negative Interpretive Data A positive result should be correlated with clinical history and may necessitate additional diagnostic procedures. Careful patient education on follow-up steps and interpretation of results is essential. This test should be used as a screening tool only; abnormal findings must be evaluated in conjunction with other clinical assessments. Note CPT Code 87624 Aliases HPV Cervical Cancer Self-Collection Self-Collected HPV Test HPV DNA Test (Self-Collected) Cervical HPV Self-Sampling

View a complete list of participating insurances here at Clinical Diagnostic Laboratories. Contact us for more information. PARTICIPATING INSURANCE COMPANIES Clinical Diagnostics Laboratories will file all claims with the below-listed insurance companies. The list below is not a complete list of Health plans with which CDL participates and is subject to change over time. There may be exceptions in certain areas or for certain members or plans. If you have any questions or do not see your insurance company listed here, please contact us. AARP Adventist HealthCare Aetna (PPO) American Postal Workers Union (APWU) AmeriGroup Health AmeriHealth Anthem Assurant Health Beechstreet Benefit Plan Administrators VA Blue Cross Blue Shield of VA PPO, KeyCare, Cova, Medicare Advantage PPO Anthem Blue Cross (PPO, Medicare PPO)Blue Cross Blue Shield of West VA BRMS Capital Blue Cross (PPO Only) Care Improvement Plus-United Health CareFirst BCBS CareLink CareNet Celtic Insurance ChoiceCare Cigna (Multiplan) Cofinity Compass Rose Conifer Health Solution CoreSource Corvel Coventry National PPO Emblem Health (PPO Only) Empire BCBS (PPO Only) Federal and State Benefit Health Plans FEHBP FedMed Inc First Health National PPO Network Fortis Insurance -Assurant Galaxy Health Network GEHA-(First Health) Geisinger Health Great West HealthAmerica HealthPartners Network HealthScope Services HealthSmart Preferred Networks Highmark BCBS (PPO Only) Horizon BCBS (PPO Only) Humana (All Plans) InterPlan Health Group-HealthSmart John Alden Insurance -Assurant Johns Hopkins Healthcare MagnaCare Mail Handlers Benefit Plan Maryland Physicians Care (MPC) MedCost (NovaNet) Medical Mutual Meritain Health Multiplan National Network NALC- Cigna, Multiplan National Capital PPO, Health Link National Care Network NCN National Claims Administrative Services (NCAS) NovaNet PPO OneNet PPO (United Health Care) Optima Health Network-Valley Health Net Paramount Health Care PayerFusion POMCO Prime Health Services Private Healthcare (PMCS) Pyramid Life Insurance Company Riverside Health(Maryland HealthChoice) Ryan White HIV/Aids Program SAMBA FEP StarMark Insurance Stratrose PPO, NPPN SummaCare PPO (Multiplan, PHCS) SuperMed PPO-1st Medical The Health Plan Three Rivers Provider Network Unicare UnitedHealthcare Virginia Health Network-MedCost Ultra, VHN Plus USA MCO Government Health Plans Medicaid VA, MD, and DC Medicare Advantage PPO Medicare Supplement Railroad Medicare Traditional Medicare Tricare Health Net Federal Services Humana Military TriCare for Life TriWest SCHEDULE AN APPOINTMENT Last Name Email Phone Type your message here... Submit Thanks for submitting! A member of our team will respond to your inquiry as soon as possible.

Ordering information regarding a Hemoglobin A1C test for Clinical Diagnostic Laboratories. Hemoglobin A1C Ordering Recommendation The Hemoglobin A1c test is a vital tool for diagnosing and monitoring diabetes mellitus, as well as assessing prediabetes. Diagnostic levels are marked by values greater than or equal to 6.5%, while monitoring involves tracking long-term glycemic control in diabetes patients. Additionally, values between 5.7% and 6.4% signal an increased risk of developing diabetes. For patients with hemoglobin variants lacking hemoglobin A, the Fructosamine test is preferred for monitoring long-term glycemic control. Mnemonic Methodology Quantitative Capillary Electrophoresis Performed Mon-Sat Reported Within 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Lavender (EDTA) Specimen Preparation: Transport whole blood in original tube. (Min: 1 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Tissue or urine. Samples frozen after 8 hrs of collection and samples frozen at temperatures less than -70C. Remarks: Stability: Ambient: 72 hours; Refrigerated: 1 week; Frozen: 3 months (Must be frozen within 8 hrs of collection at -70 to -80C) Reference Interval Components Available Separately Reference Interval No Hemoglobin A1C Less than 5.7 percent No Estimated Average Glucose By report Interpretive Data HbA1c values of 5.7-6.4 percent indicate an increased risk for developing diabetes mellitus. HbA1c values greater than or equal to 6.5 percent are diagnostic of diabetes mellitus. For diagnosis of diabetes in individuals without unequivocal hyperglycemia, results should be confirmed by repeat testing. Note This assay accurately measures hemoglobin A1c even in the presence of hemoglobin variants, provided hemoglobin A is present. For patients with known hemoglobin variants who lack hemoglobin A, it is recommended to monitor long-term glycemic control using the Fructosamine test CPT Code 83036 Components Component Test Code 0070427 0070428 Component Chart Name Estimated Average Glucose LOINC Hemoglobin A1C 27353-2 4548-4 Aliases Hemoglobin A1C A1C A1C Hemoglobin Glycated Hemoglobin Glyco HGB Glyco-Hb Glycosylated Hemoglobin HA1C HbA1c Hemoglobin A1C Hemoglobin A1C, Blood

Ordering information regarding a Cyclic Citrullinated Peptide (CCP) Antibody, IgG test for Clinical Diagnostic Laboratories. Cyclic Citrullinated Peptide (CCP) Antibody, IgG Ordering Recommendation Highly specific serologic test that aids in the workup of suspected rheumatoid arthritis or undifferentiated inflammatory arthritides. Rheumatoid Arthritis Panel (3004055 ) is the preferred test. Mnemonic Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Urine or plasma. Contaminated, hemolyzed, grossly icteric, heat-inactivated, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval 19 Units or less 20-39 Units Negative Weak Positive 40-59 Units Moderate Positive 60 Units or Greater Strong Positive Interpretive Data Anti-cyclic citrullinated peptide (anti-CCP), IgG antibodies are present in about 69-83 percent of patients with rheumatoid arthritis (RA) and have specificities of 93-95 percent. These autoantibodies may be present in the preclinical phase of disease, are associated with future RA development, and may predict radiographic joint destruction. Patients with weak positive results should be monitored and testing repeated. Note CPT Code 86200 Components Component Chart Name Cyclic Citrullinated Peptide Ab, IgG Component Test Code 0055256 LOINC 33935-8 Aliases ACPA Antibody Anti Citrullinated Antibody Anti Citrulline Anti-CCP Anti-CCP Antibody Anti-Citrullinated Ab Anti-Citrullinated Antibody Anti-Citrullinated Protein/Peptide Antibody (ACPA) Anti-Citrulline Antibody Anti-Cyclic Citrullinated Peptide AntiCCP Antibody Anticitrullinated Antibody Anticitrullinated Protein/Peptide Antibody (ACPA) Anticitrulline Antibody Anticyclic Citrullinated Peptide (CCP) Antibody CCP CCP3 Antibody Citrullinated Ab Citrullinated Antibody Citrullinated Protein/Peptide Antibody (ACPA) Citrulline An tibody Soft-CCP

Ordering information regarding a Lipid Panel test for Clinical Diagnostic Laboratories. Lipid Panel Ordering Recommendation Use to assess cardiovascular disease risk and guide therapy. Mnemonic Methodology Quantitative Enzymatic Assay Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Refer to individual components. Collect: Plasma separator tube or serum separator tube. Specimen Preparation: Allow serum tube to clot completely at room temperature. Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to a standard transport tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Body fluid (refer to Cholesterol, Fluid; Triglycerides, Fluid; and Chylomicron Screen, Body Fluid). Remarks: Stability: After separation from cells: Ambient: 24 hours; Refrigerated: 7 days; Frozen: 3 months Reference Interval Interpretive Data An HDL cholesterol less than 40 mg/dL is low and constitutes a coronary heart disease risk factor. An HDL cholesterol greater than 60 mg/dL is a negative risk factor for coronary heart disease. Non-HDL cholesterol is a secondary target of therapy in persons with high serum triglycerides (greater than 199 mg/dL). The goal for non-HDL cholesterol in persons with high triglycerides is 30 mg/dL higher than their LDL cholesterol goal. CHD Risk Factors +1 Men, 45 years and older +1 Women, 55 years and older or premature menopause without estrogen therapy +1 Family history of premature CHD +1 Current smoking +1 Hypertension +1 Diabetes mellitus +1 Low HDL cholesterol: 39 mg/dL or less -1 High HDL cholesterol: 60 mg/dL or greater Desirable Adult Values Higher Risk Borderline Total Cholestorol Triglycerides 199 mg/dL or less 149 mg/dL or less 200-239 mg/dL 150-199 mg/dL 240 mg/dL or greater 200-499 mg/dL HDL Cholestorol LDL Cholesterol (calculated) 40 mg/dL or greater 129 mg/dL or less (99 mg/dL or less if patient has CHD) 39 mg/dL or less 130-159 mg/dL 160 mg/dL or greater VLDL Cholesterol (calculated) 30 mg/dL or less Desirable Children & Adolescents Higher Risk Borderline Total Cholestorol 169 mg/dL or less 170-199 mg/dL Triglycerides 149 mg/dL or less 150-199 mg/dL HDL Cholestorol LDL Cholesterol (calculated) 40 mg/dL or greater 109 mg/dL or less 110-129 mg/dL VLDL Cholesterol (calculated) 30 mg/dL or less 200 mg/dL or greater 200-499 mg/dL 39 mg/dL or less 130 mg/dL or greater Note CPT Code 80061 Components Component Test Code 0020031 0020040 0020051 0020053 0020551 0020705 0020008 0020023 0020024 0020025 0020027 0020029 0020030 0020032 0020396 3004293 Component Chart Name Sodium, Serum or Plasma Potassium, Serum or Plasma Chloride, Serum or Plasma Carbon Dioxide, Serum or Plasma Alkaline Phosphatase Aspartate Aminotransferase Alanine Aminotransferase Urea Nitrogen, Serum or Plasma Glucose, Serum or Plasma Creatinine, Serum or Plasma Calcium, Serum or Plasma Protein Total, Serum/Plasma Albumin, Serum or Plasma Bilirubin, Total, Serum or Plasma Anion Gap UH EGFR LOINC 2951-2 2823-3 2075-0 2028-9 6768-6 1920-8 1742-6 3094-0 2345-7 2160-0 17861-6 2885-2 1751-7 1975-2 33037-3 Aliases ACPA Antibody Anti Citrulline Anti-CCP C12 Chem 12 Chemistry Panel Chemistry Screen CMP SMA 12 SMA 20 SMAC

Ordering information regarding a T- Uptake test for Clinical Diagnostic Laboratories. T Uptake Ordering Recommendation The preferred alternative to this test is Thyroxine, Free (Free T4) Methodology Quantitative Electrochemiluminescent Immunoassay (ECLIA) Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube or green (lithium heparin). Also acceptable: lavender Specimen Preparation: Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Grossly hemolyzed specimens. Remarks: Stability: After separation of cells: Ambient: 8 days; Refrigerated: 2 weeks; Frozen: 2 years Reference Interval Components Available Separately Reference Interval Thyroxine, Total T4 0.8-1.3 TBI Interpretive Data Thyroxine, Free (Free T4) is the preferred test alternative for T Uptake and Free Thyroxine Index tests. Note CPT Code 84479 Components Component Test Code Component Chart Name LOINC 3005979 T Uptake 74795-6 Aliases T3 Uptake T4 uptake, S T4U, Serum TBC THBR Thyroid Binding Ratio Thyroxine-binding capacity Throxine Binding Index Triiodothyronine uptake, serum

Services for Life Insurance Companies We Care About Your Applicants Clinical Diagnostics Laboratories cares about your applicants and their goal to acquire life insurance. We promise to provide your life insurance applicants with professional laboratory testing to assist in their application process that is done with dignity. We provide laboratory testing using state-of-the-art testing equipment. With the ability to gain results in 24hrs with easy scheduling options . Our highly skilled professionals are on standby to treat your applicants with the highest degree of care and efficiency. Click here today to get started. Contact Us

The Terms and Conditions of Clinical Diagnostic Laboratories located in Sterling and Ashburn is located on this page. Terms & Conditions 1. Acceptance of Terms Welcome to Clinical Diagnostic Laboratories ("we," "us," or "our"). By accessing or using our services, including our website and any related applications (collectively referred to as the "Services"), you agree to comply with and be bound by these Terms and Conditions. If you do not agree to these terms, please refrain from using our Services. 2. Services Offered Clinical Diagnostic Laboratories provides comprehensive diagnostic testing services including, but not limited to, blood panels, allergy tests, COVID tests, and Influenza tests. These services are available at our two separate locations: 2 Pidgeon Hill Dr., Suite 150, Sterling, VA 20165, and 44355 Premier Plaza, Suite 240, Ashburn, VA 20147. 3. Test Accuracy and Interpretation While we strive to provide accurate and reliable test results, it is important to note that medical tests may have limitations and potential variations. Test results should be interpreted by qualified medical professionals, and we strongly recommend consulting a healthcare provider for accurate diagnosis and treatment recommendations based on the test results. 4. Privacy and Data Security We are committed to protecting your privacy and the security of your personal and medical information. Our Privacy Policy outlines the types of data we collect, how it is used, and the measures we take to safeguard your information. By using our Services, you agree to our Privacy Policy. 5. Payment and Billing We offer various payment options for our services. Payment details, including pricing and payment methods, are available on our website and will be provided during the checkout process. Any additional fees, taxes, or charges associated with the services will be clearly communicated. 6. Appointments and Cancellations Appointments for tests are subject to availability and can be scheduled through our website or by contacting our customer service. If you need to cancel or reschedule an appointment, please provide notice in advance according to our cancellation policy, which will be communicated during the appointment scheduling process. 7. Test Preparation Instructions Specific tests may require certain preparations, such as fasting or medication restrictions. Customers are responsible for following these instructions to ensure accurate test results. 8. Turnaround Time for Results We strive to provide test results within a specific timeframe. However, factors such as test complexity and demand may impact the turnaround time. 9. Refund and Return Policy If services are paid for but not utilized, our refund and return policy applies. Details can be found on our website or obtained by contacting customer service. 10. Communication Channels For inquiries, support, or appointment scheduling, contact us via email, phone, or our designated customer portal. 11. Insurance and Coverage Information about insurance coverage, billing procedures, and reimbursement for services covered by insurance can be found on our website or by contacting us directly. 12. Laboratory Accreditation and Certifications Clinical Diagnostic Laboratories maintains specific accreditations and certifications that demonstrate our commitment to q uality and accuracy. 13. Health and Safety Measures To ensure a safe testing environment, we adhere to rigorous health and safety protocols for the protection of both patients and staff. 14. Dispute Resolution Any disputes will be resolved through mediation or arbitration, with the applicable jurisdiction specified. 15. Legal Disclaimers Our services are for diagnostic purposes only. Customers should consult healthcare professionals for medical advice and treatment. 16. User Accounts (if applicable) If you create a user account on our platform, terms related to account creation, management, and security apply. 17. Governing Law These Terms and Conditions are governed by and construed in accordance with the laws of the state of Virginia, without regard to its conflict of laws principles. 18. Conta ct Us If you have any questions, concerns, or feedback regarding these Terms and Conditions or our Services, please contact us at: Clinical Diagnostic Laboratories 2 Pidgeon Hill Dr., Suite 150, Sterling, VA 20165 44355 Premier Plaza, Suite 240, Ashburn, VA 20147 Email: info@clinicaldiagnosticlab.com Phone: (703) 430-1111 Fax: (703) 722-3890

Ordering information regarding a Tryptase test for Clinical Diagnostic Laboratories. Tryptase Ordering Recommendation Measure total tryptase to confirm mast cell activation in diseases such as mastocytosis, anaphylaxis, urticaria, and asthma. Not generally used acutely except where the diagnosis is unclear. Useful in the prognosis of systemic mastocytosis. Mnemonic EGGWHOLE Methodology Quantitative ImmunoCAP Fluorescent Enzyme Immunoassay Performed Mon-Sat Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Allow serum to clot completely at room temperature. Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.5 mL) Storage/Transport Temperature: Frozen. Unacceptable Conditions: Hemolyzed, icteric, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 72 hours; Frozen: 1 month Reference Interval Less than 11.0 µg/L Interpretive Data Compliance Category: FDA Note This test measures total tryptase and does not distinguish between the alpha and beta protein types. Samples should preferably be collected between 15 minutes and three hours after the event suspected to have caused mast cell activation. CPT Code 83520 Components Component Chart Name Tryptase Component Test Code 0099173 LOINC 21582-2 Aliases Total Tryptase Tryptase, Autopsy (Tryptase)

Did you have a test with Clinical Diagnostic Laboratories? Check here to access your results. Patient Test Results If you provided a doctor's order/referral, your results will be delivered to your physician either via fax or via their portal (if they have established an account with us). If you did not provide an order/referral, your results will be sent to you directly via email in the form of a PDF file. Patients are able to request a copy of their results at any time. If you'd like to request a copy of your lab results, please contact us using the button below. Email Us About Lab Results